Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.
CeO Immunology, Danone Nutricia Research, Utrecht, The Netherlands.
Immun Inflamm Dis. 2020 Mar;8(1):93-105. doi: 10.1002/iid3.288. Epub 2020 Feb 7.
Amino acid-based formulas (AAFs) are used for the dietary management of cow's milk allergy (CMA). Whether AAFs have the potential to prevent the development and/or symptoms of CMA is not known.
The present study evaluated the preventive effects of an amino acid (AA)-based diet on allergic sensitization and symptoms of CMA in mice and aimed to provide insight into the underlying mechanism.
C3H/HeOuJ mice were sensitized with whey protein or with phosphate-buffered saline as sham-sensitized control. Starting 2 weeks before sensitization, mice were fed with either a protein-based diet or an AA-based diet with an AA composition based on that of the AAF Neocate, a commercially available AAF prescribed for the dietary management of CMA. Upon challenge, allergic symptoms, mast cell degranulation, whey-specific immunoglobulin levels, and FoxP3 cell counts in jejunum sections were assessed.
Compared to mice fed with the protein-based diet, AA-fed mice had significantly lower acute allergic skin responses. Moreover, the AA-based diet prevented the whey-induced symptoms of anaphylaxis and drop in body temperature. Whereas the AA-based diet had no effect on the levels of serum IgE and mucosal mast cell protease-1 (mMCP-1), AA-fed mice had significantly lower serum IgG2a levels and tended to have lower IgG1 levels (P = .076). In addition, the AA-based diet prevented the whey-induced decrease in FoxP3 cells. In sham-sensitized mice, no differences between the two diets were observed in any of the tested parameters.
This study demonstrates that an AA-based diet can at least partially prevent allergic symptoms of CMA in mice. Differences in FoxP3 cell counts and serum levels of IgG2a and IgG1 may suggest enhanced anti-inflammatory and tolerizing capacities in AA-fed mice. This, combined with the absence of effects in sham-sensitized mice indicates that AAFs for the prevention of food allergies may be an interesting concept that warrants further research.
氨基酸配方(AAFs)用于牛奶过敏(CMA)的饮食管理。AAFs 是否有潜力预防 CMA 的发生和/或症状尚不清楚。
本研究评估了氨基酸(AA)基饮食对小鼠牛奶过敏的过敏致敏和症状的预防作用,并旨在深入了解其潜在机制。
C3H/HeOuJ 小鼠用乳清蛋白或磷酸盐缓冲盐水作为假致敏对照致敏。从致敏前 2 周开始,小鼠分别用蛋白质基础饮食或 AA 基础饮食喂养,AA 组成基于市售用于 CMA 饮食管理的 AAF Neocate。在挑战时,评估过敏症状、肥大细胞脱颗粒、乳清特异性免疫球蛋白水平和空肠切片中的 FoxP3 细胞计数。
与用蛋白质基础饮食喂养的小鼠相比,用 AA 喂养的小鼠的急性过敏皮肤反应明显较低。此外,AA 基础饮食可预防乳清引起的过敏症状和体温下降。虽然 AA 基础饮食对血清 IgE 和黏膜肥大细胞蛋白酶-1(mMCP-1)水平没有影响,但 AA 喂养的小鼠的血清 IgG2a 水平明显较低,且 IgG1 水平有降低趋势(P=0.076)。此外,AA 基础饮食可预防乳清诱导的 FoxP3 细胞减少。在假致敏小鼠中,两种饮食在所有测试参数中均无差异。
本研究表明,AA 基础饮食至少可以部分预防小鼠的 CMA 过敏症状。FoxP3 细胞计数以及血清 IgG2a 和 IgG1 水平的差异可能表明 AA 喂养的小鼠具有增强的抗炎和耐受能力。这与假致敏小鼠无影响相结合表明,AAF 用于预防食物过敏可能是一个有趣的概念,值得进一步研究。